Spontaneous induction of NCC-like cells in hPSC aggregates
To induce NCCs from hPSC, we cultured hPSC aggregates in a defined medium (NCCind medium) (Fig. 1a). Day-5 aggregates were enriched in SOX10+ NCC-like cells. However, they contained a small number of PAX6+ neuroepithelial cell (NEC) and CDH1+ non-neural epithelium (NNE) cells (Fig. 1b). Knockout serum replacement (KSR), which is often used in neural tissue induction, reduced the induction of NCC-like cells (Supplementary Fig. 1)13,14. Therefore, we added B-27 supplement instead of KSR to improve cell viability and we analyzed the gene expression during differentiation (Fig. 1c). The hPSC marker NANOG was downregulated on the first day. One of the earliest NCC markers, PAX7, was also upregulated. Subsequently, the early NCC marker FOXD3 and the late marker SOX10 were upregulated. We confirmed the expression of these genes using immunohistochemistry (IHC) (Fig. 1d). Under our experimental conditions, we detected cells co-expressing all these markers in the peripheral region of the aggregates from day 3. The expression of FOXD3 and SOX10 mostly overlapped at every stage tested, although the expression of FOXD3 seemed to be weaker on day 5 than on day 4. In model animals, such as chicks and zebrafish, FOXD3 and SOX10 are expressed in distinct but partially overlapping patterns, and FOXD3 seems to be downregulated as development proceeds15,16. Weaker expression of FOXD3 at day 5 may reflect the downregulation observed in vivo. The expression of PAX7 was broader than that of the others, especially on day 4 (Fig. 1d, e). FOXD3–/SOX10–/PAX7+ cells might be earlier NCC precursor-like cells or other types of cells, such as dorsal NECs17.
As day-5 aggregates contained non-NCC-type cells (Fig. 1b), we analyzed the content of aggregates derived from KhES-1 cells by using single-cell RNA-seq (scRNA-seq). A total of 1877 cells were divided into 14 clusters using unsupervised uniform manifold approximation and projection (UMAP) clustering (Fig. 2a, b). Clusters 0, 1, 3, 4, 5, 6, and 7 represented SOX10+ NCC-like cells, accounting for 71.9% of the total cells (Fig. 2c, d). The expression of PAX7 and FOXD3 was higher in cluster 5 than in the NCC-like clusters, indicating that cluster 5 represented nascent NCC-like cells (Fig. 2e, g). The presence of PAX7high/FOXD3high cells was confirmed using IHC (Fig. 1d). Cluster 8, adjacent to cluster 5, represented SP5+/PAX7 +/FOXD3+ NPB-like cells (Fig. 2f, g)18. Cluster 8 was also characterized by extremely low SOX10 expression (Fig. 2b, d, g). Cluster 9 represented more immature cells, characterized by higher POU5F1 expression and the absence of SOX17 expression, a marker gene for endodermal cells (Endo) (Fig. 2h)19. Cluster 10 contained CDH1+/TFAP2A+ NNE-like cells, which also contained SIX1+ pre-placodal epithelium (PPE)-like cells (Fig. 2i)20. Three types of neural lineage clusters were observed (Fig. 2j). Cluster 2 appeared to represent ISL1+/SIX1+ NCC-derived neuron-like cells (Fig. 2i, j)21 and cluster 11 contained PAX6+/EMX2+ NEC-like cells (Fig. 2j)22. Cluster 13 comprised EBF2+ placode-derived neuron-like cells (Fig. 2j)23. Cluster 12 represented SOX17+ endo-like cells (Fig.2h). We also confirmed the presence of these cell types using IHC (Supplementary Fig. 2).
Although p75 is not specific to NCCs in human embryos24, scRNA-seq revealed that p75 expression was mostly specific to NCC-like cells in day-5 aggregates (Supplementary Fig. 3a). IHC also showed that p75 expression was specific to SOX10+ cells (Supplementary Fig. 3b, c). Almost consistent with scRNA-seq data, 76.5% of the cells in day-5 aggregates derived from KhES-1 expressed p75 at a high level on average (Supplementary Fig. 3d). Although the induction efficiency of SOX10+ cells varied among the hPSC lines, the expression of p75 appeared to be specific to SOX10+ cells in all cell lines (Supplementary Fig. 3b–d). These results indicate that p75 could be a suitable surface antigen for isolating NCC-like cells in this experimental system. We also tested the multipotency of these NCC-like cells (Supplementary Fig. 4). These cells can differentiate into neuronal cells, glial cells, melanoblasts, and ectomesenchymal derivatives, including smooth muscle cells, osteoblasts, chondroblasts, and adipocytes.
In our method, NCC-like cells were spontaneously induced without additives, such as CHIR-99021, BMPs, and SB-431542 (SB) that are often used in other methods4,5,6,7, indicating the importance of aggregate-intrinsic signals. We analyzed the role of aggregate-intrinsic WNT/BMP signals, considering their importance in vivo (Fig. 3a)8. WNT1/4 were expressed in aggregates and peaked on days 3 and 4. AXIN2, a well-known downstream target of the canonical WNT signal25, also peaked around days 3 and 4. A non-canonical WNT, WNT7B, was upregulated on day 1. BMP2 was also upregulated around day 3, whereas BMP4 was upregulated between days 0 and 1, suggesting that BMP4 may play a role in the early phase of differentiation. To reveal the function of WNT/BMP signals in our method, we treated the aggregates with the WNT inhibitor IWP-2 or the BMP inhibitor dorsomorphin (Fig. 3b). We added these inhibitors from days 1, 2, or 3 to day 5 and analyzed the expression of marker genes for NCC-like cells (SOX10), NEC-like cells (PAX6), NNE-like cells (CDH1), and PPE-like cells (EYA1) (Fig. 3c). WNT inhibition starting on day 1 strongly suppressed SOX10 (Fig. 3c). This effect was weakened when IWP-2 was added on day 2. Treatment from day 3 showed almost no effect, suggesting that WNT signaling before day 3 was important for NCC-like cell induction. However, canonical WNT activity was upregulated from day 3, suggesting the importance of the early expression of non-canonical WNTs, such as WNT7B. BMP inhibition on day 1 also suppressed SOX10 expression, although this suppression was incomplete. This indicates that BMPs, such as BMP4, might act from day 0, and that their activities were sufficient to induce the differentiation of subsets of NCC-like cells. BMP inhibition on day 3 was also ineffective on SOX10 expression. For PAX6, CDH1, and EYA1, both WNT and BMP inhibition from day 3 had almost no effect, indicating that the fate of most precursors was determined by day 3 (Fig. 3c). WNT inhibition from days 1 and 2 slightly upregulated CDH1 and EYA1, indicating an increase in the number of NNE/PPE-like cells. Conversely, BMP inhibition on day 1 significantly reduced the expression of CDH1 and EYA1, indicating a reduction in the number of NNE/PPE-like cells. BMP inhibition from day 1 also resulted in the upregulation of PAX6, indicating an increase in the number of NEC-like cells, which was consistent with a reduction in NNE/PPE marker expression. Interestingly, WNT inhibition from days 1 and 2 also upregulated PAX6, although NNE/PPE markers were also upregulated under these conditions. We analyzed the aggregates treated with inhibitors from day 1 using IHC (Fig. 3d, e). Consistent with the results of real-time polymerase chain reaction (PCR), an increase in the number of PAX6+ cells and a decrease in those of SOX10+ and CDH1+ cells were observed in the dorsomorphin-treated aggregates. In contrast, SOX10+ cells disappeared completely from the IWP-2-treated aggregates (Fig. 3d). In IWP-2-treated aggregates, the counts of PAX6+ cells were increased, as well as in dorsomorphin-treated aggregates, but these PAX6+ cells expressed CDH1, suggesting that they were of the NNE/PPE-like lineage. PAX6 is also expressed in the anterior PPE, such as the lens/olfactory placodes26. We confirmed that there were SIX1+/CDH1+ cells that did not express PAX6 in non-treated aggregates, while many SIX1+/CDH1+ cells co-expressed PAX6 in IWP-2-treated aggregates, suggesting that they became anterior PPE-like cells (Fig. 3e). Anteriorization by WNT inhibition is consistent with the role of WNT signals in the posteriorization of embryonic ectodermal tissue during early development27. For dorsomorphin-treated aggregates, there were hardly any CDH1+ NNE/PPE-like cells. These results indicate that aggregate-intrinsic WNT and BMP signals regulate the positional identity of cells to induce NCC-like cells (Fig. 3f).
SB, which antagonizes activin/TGFß signal, was also used in some NCC induction methods4,6. We tested the effect of SB on our NCC-like cell induction method by adding SB from day 0 onward. In SB-treated aggregates, the number of NCC-like cells expressing FOXD3 and SOX10 increased, while SOX17+ endo-like cells disappeared on day 4 (Supplementary Fig. 5). This result is consistent with the finding that SB inhibits the endodermal induction of hPSCs while facilitating neuroectodermal differentiation28.
Recapitulation of in vivo differentiation process during NCC-like cell induction
We appended the scRNA-seq data of day-2, day-3, and day-4 aggregates to the data of day-5 aggregates for further analysis of the developmental process of the aggregate (total 8466 cells, 23 clusters) (Fig. 4a). The cells in the cluster 15 were POU5F1+/NANOG+/EOMES–, indicating that they exhibited a PSC-like state (Fig. 4b)29. The early NPB marker TFAP2A, which can induce the expression of NCC marker genes when overexpressed in hPSCs30, was upregulated in cluster 7 adjacent to cluster 15, and its expression continued throughout differentiation into NCC-like and NNE/PPE-like cells (Fig. 4c). The NPB markers, SP5 and IRX1, were upregulated in groups of clusters adjacent to cluster 7 (clusters 3, 6, 8, 9, 13, 14, 16, and 19) (Fig. 4d)18,31. Another group of clusters (clusters 1, 2, 4, 5, 11, 17, and 20) contained SOX10+ NCC-like cells (Supplementary Fig. 6). In this group, some marker genes showed differential expression patterns, suggesting variations in cell state (Supplementary Fig. 6). Cluster 0 was the transition point between the NPB-like and NCC-like clusters expressing FOXD3 and SOX9 at high levels (Fig. 4e and Supplementary Fig. 6). Cluster 10 contained SIX1+ NCC-derived neuron-like cells (Fig. 4f). Clusters 12/18 contained KRT18 high NNE/PPE-like cells, and cluster 22 contained PAX6+ NEC-like cells (Fig. 4f). Cluster 21 contained SOX17 + endo-like cells (Fig. 4g). RNA velocity analysis suggested that most of the hPSCs differentiated into NPB-like states. However, only a small number of cells differentiated into SOX17+ endo-like cells (Fig. 4h). NPB-like cells seemed to differentiate into NCC-like-, NEC-like-, and NNE/PPE-like cells, suggesting that NPB-like cells are multipotent, as observed in model animals (Fig. 4h)32,33,34.
NPB is located between SOX2+ NE and TFAP2A+ NNE, and both genes are expressed in model animals32. In our scRNA-seq dataset, we observed the co-expression of SOX2 and TFAP2A NPB-like clusters at all stages analyzed (Supplementary Fig. 7a). We also confirmed co-expression in the aggregates using IHC (Supplementary Fig. 7b). Co-expression of SOX2 and TFAP2A clearly appeared on day 2. However, TFAP2A was already expressed in some SOX2+ cells weakly at day 1. From day 4, SOX2 expression decreased in most TFAP2A+ cells, including NPB-like, NCC-like, and NNE/PPE-like cells. This downregulation of SOX2 has been observed in the NCCs of chick embryos32. Some SOX2+/TFAP2A+ cells also co-expressed PAX7 from day 3, similar to the NPB cells in chick embryos (Supplementary Fig. 7b).
We analyzed the NPB clusters in more detail to identify the variety in the cell state. NPB clusters (clusters 3, 6, 7, 8, 9, 12, 13, 14, 16, and 19) were extracted according to the expression of SP5 and TFAP2A and re-clustered to identify differentially expressed genes (Supplementary Fig. 8a). SP5 and IRX1 were broadly expressed. The cranial NCC (cNCC) markers, LHX5, DMBX1, and OTX2, were also expressed in a large number of cells, although the expression patterns of DMBX1 and OTX2 were sparse and restricted, compared with LHX5, respectively. Lhx5 and Dmbx1 are regulators of the cNCC-specific gene regulatory network in chick embryo35. Otx2 is crucial for head development36. These results suggest that most NPB-like cells possess a cNCC-like identity.
The NPB-like cell clusters could be roughly classified into two groups (Supplementary Fig. 8c, d). One group expressed genes related to the anterior patterning of the embryonic ectoderm, such as CYP26A1 and HESX137,38. This group mainly comprised cells of early differentiation days (day 2: 85.0%, day 3: 14.6%, day 3: 0.4%, and day 4: 0%). In the other group, NPB-specified PAX3 and MSX1 were broadly expressed instead of CYP26A1 and HESX1. This group comprised cells from late differentiation days (day 2: 13.8%, day 3: 26.9%, day 3: 29.6%, and day 4: 29.7%). This result suggests that early anterior patterning of the ectoderm occurred in the aggregates, followed by further differentiation of NPB-like cells.
We also searched for genes with distinct expression patterns within NPB-like cell clusters, focusing on transcription factors (Supplementary Fig. 9). For example, FOXD3, ZFHX4, TFAP2B, DACH1, and EBF1 are expressed in cells located on the left side of the UMAP. These genes are also expressed in NCCs in vivo39,40,41,42. PAX6, EN1, PAX2, PAX7, OTX2, GBX2, and EMX2, which are essential factors for the patterning of NECs around the diencephalon and mid/hindbrain, also exhibited distinct patterns22,43, suggesting those factors may define the axial identity of NPB-like cells in the aggregates. DLX5, GRHL2, GRHL3, MAFB, and HAND1 also showed characteristic expression patterns in NPB-like cells, and their expression extended to NNE/PPE-like cell clusters. These genes are involved in the NNE/PPE lineage development in vivo44,45,46,47. The tumor suppressor ELF3 is also expressed in similar patterns, although its role in NPB-like cells is unknown48.
Furthermore, a trajectory analysis of NPB-like cells was performed to identify gene expression patterns specific to the trajectories bound for each ectodermal lineage (Supplementary Fig. 10a). Some genes exhibited differential expression patterns among the different lineages (Supplementary Fig. 10b). These genes included those known to be important for the development of each lineage, as earlier mentioned. There were also several lineage-specific genes whose roles in the differentiation of NPB-like cells were unknown, such as EBF1 and SEZ6 for the NCC-like lineage and ELF3, KLF6 for the NNE/PPE-like lineage. For example, EBF1 is known for its expression in migratory cNCC, but its function in NPB is unknown41, similar to that of ELF3.
To infer the gene expression dynamics during the differentiation of NCC-like cells, pseudotime analysis was performed on clusters, excluding NNE/PPE-like, NEC-like, and endo-like cell clusters (Fig. 4i). Markers for PSC, NPB, and NCC were upregulated along with pseudotime, indicating the recapitulation of the in vivo NCC induction processes to some extent (Fig. 4j). During in vivo development, EMT is associated with the induction of NCCs as they leave their origin. EMT is characterized by several features, such as the expression of EMT-inducing transcription factors, changes in the expression of cadherin genes, and degradation of the basement membrane49. Gene ontology analysis of cluster markers revealed that in marker genes for cluster 0 of the merged scRNA-seq data, which was a junction between NPB and NCC-like cells, were enriched with genes related to EMT (i.e., GO:0001837 “epithelial to mesenchymal transition”) (Supplementary Fig. 11). Pseudotime analysis revealed temporal changes in the expression of several genes related to EMT, including transcription factors and cadherins (Fig. 5a). Consistent with their regulatory relationships, the expression of PAX3/7 and MSX1 was higher than that of FOXD3, ETS1, and SNAI2 50. Furthermore, the downregulation of CDH2 coincided with the expression of SNAI2 and LMO450. Changes in cadherin expression in the aggregates were analyzed by IHC. Epithelial cadherin CDH1 was expressed in the aggregates almost entirely on day 2 and then gradually restricted as differentiation proceeded (Fig. 5b). Most CDH1– regions were occupied with FOXD3+ cells. SOX10+ cells in day-4 aggregates expressed the EMT-related cadherin CDH6 with a complementary pattern to CDH1, indicating the switching of cadherins during NCC-like cell differentiation (Fig. 5c). These results suggest that the in vitro induction of NCC-like cells may recapitulate the in vivo developmental processes to some extent (Fig. 5d).
Induction of branchial arch mesenchyme-like aggregates with specific regional identity
We tested the potential of these aggregates as in vitro models of early craniofacial development. As earlier mentioned, the expression of DMBX1, LHX5, OTX2 (Supplementary Fig. 8b), and ETS1 (Fig. 5a) suggested that the induced NCC-like cells possessed a cranial identity (Fig. 5a, Supplementary Fig. 8b)35,36. cNCCs migrating into future craniofacial regions are HOX-negative in vivo51. We were unable to detect HOX-positive NCC-like cells in the aggregates, indicating that the cells in the aggregates possessed the ability to differentiate into the craniofacial mesenchyme (Supplementary Fig. 12).
We performed a long-term culture of the aggregates to induce craniofacial mesenchyme-like cells. The addition of basic fibroblast growth factor (bFGF) from day 4 enabled long-term culture, preventing the collapse of the aggregates during the culture period (Fig. 6a). bFGF-treated aggregates expressed the craniofacial mesenchyme markers PRRX1 and TWIST1 at higher levels than untreated aggregates (Fig. 6b)52. IHC of day-28 aggregates revealed that many cells expressed these genes, indicating the induction of craniofacial mesenchymal-like cells (Fig. 6d, e). The branchial arch markers, DLX2 and BARX1, were also expressed in day-28 aggregates (Fig. 6b, e, f)53. These aggregates also expressed LHX6, a specific marker expressed on the oral side of the first branchial arch mesenchyme in a spatially restricted manner, as observed in vivo (Fig. 6b, e)54. The first branchial arch is composed of the MX and MN, which give rise to the upper and lower jaws, respectively. bFGF-treated aggregates expressed POU3F3, which was strongly expressed in early MX9, but did not express the MN marker DLX5 (Fig. 6b and Supplementary Fig. 13), indicating that bFGF-treated aggregates acquired an MX-like identity (Fig. 6c).
The choice of fate between MX and MN is regulated by the peptide hormone EDN110,55. EDN1 is secreted from the epithelium surrounding the MN and is essential for the induction of MN specifiers, such as DLX5/6 (Fig. 7a). Loss of the EDN1 signal results in the transformation of the lower jaw into an upper jaw-like structure10, whereas overactivation transforms the MX into an MN-like identity55. However, the NCC-like cells in the aggregates expressed the EDN1 receptor EDNRA (Fig. 7b), and the aggregates comprised only a small number of NNE-like cells, a possible source of EDN1. We hypothesized that low levels of EDN1 in the aggregates would result in the acquisition of an MX-like identity during long-term culture. Therefore, we cultured the aggregates with or without EDN1 and BMP4 from day 4 in the presence of bFGF (Fig. 7c). BMP4 is also secreted from the craniofacial epithelium and is important for the patterning of MN11. When EDN1 and BMP4 were added, POU3F3 was downregulated, whereas DLX5 was upregulated (Fig. 7d). DLX5 expression was higher in the aggregates treated with both EDN1 and BMP4 than in those treated with either EDN1 or BMP4 alone. However, the cooperative effect of EDN1 and BMP4 on DLX5 expression has not been reported previously.
The MN is divided into several subdomains (Fig. 7e). We analyzed the expression of domain-specific genes to characterize the MN-like cells induced by EDN1/BMP4 (Fig. 7f). EDN1/BMP4-treated aggregates expressed the distal region markers HAND2 and MSX2. However, MSX2 expression was upregulated when BMP4 was added alone. EDN1/BMP4-treated aggregates also expressed the intermediate region markers DLX3 and NKX3.256. Regarding the oral-aboral axis, the aboral marker GSC was upregulated in the EDN1/BMP4-treated aggregates, whereas the oral side marker LHX6 was downregulated. Furthermore, in the EDN1/BMP4-treated aggregates, WNT5A, which regulates the proper morphogenesis of MN, was also upregulated57. We confirmed the expression of these markers in EDN1/BMP4-treated aggregates using IHC (Fig. 7h, i). These results suggested that the aggregates were similar to the in vivo branchial arch mesenchyme in their responsiveness to signaling factors, and that EDN1 and BMP4 cooperatively induced the identity of the aboral side of the distal, intermediate regions of the MN (Fig. 7g).
Formation of the patterned branchial arch-like aggregates through temporary treatment
The MX and MN can be recognized as the dorsal and ventral sides of the same tissue, as the most dorsal side is POU3F3+ MX and the ventral side is HAND2+ region of the MN (Fig. 8a). At day14, in bFGF-treated aggregates that differentiated into an MX-like state, most NCC cells still expressed SOX10 (Supplementary Fig. 14). In contrast, in EDN1/BMP4-treated aggregates that differentiated into an MN-like state, most mesenchymal cells expressed DLX5 instead of SOX10, indicating fate commitment into the MN-like lineage. However, in these aggregates, a subset of cells still expressed SOX10, suggesting that they were not committed to the MN-like lineage and could differentiate into the MX-like state if EDN1 and BMP4 were removed from the medium. We tested whether single aggregates contained both POU3F3+ (dorsal MX-like) and HAND2+ (ventral MN-like) cells by removing EDN1 and BMP4 from the medium on day14 (Fig. 8b). The temporarily treated aggregates (condition 2 in Fig. 8b) expressed both POU3F3 and HAND2 at higher levels than the EDN1/BMP4-treated (condition 3 in Fig. 8b) and non-treated aggregates (condition 1 in Fig. 8b) on day 21(Fig. 8c). Furthermore, POU3F3+ and HAND2+ cells formed spatially separated domains in temporarily treated aggregates, indicating mutually exclusive fate choice and self-patterning properties of cells (Fig. 8d).
We analyzed previously reported scRNA-seq data from the mouse branchial arch on embryonic day 9.5 (E9.5) as a reference58. Hox-negative cells were extracted from NCC clusters and re-clustered (Supplementary Fig. 15a). There were clusters positive for the MN markers Dlx5 and Hand2 (clusters 1, 2, and 7) and clusters positive for the MX arch marker Pou3f3 (clusters 0, 3, 5, and 6). Several presumptive markers for these clusters were identified (Supplementary Fig. 15b). On day 21, EDN1/BMP4-untreated aggregates expressed the presumptive MX arch markers EBF1 and POU3F1 at higher levels, and EDN1/BMP4-treated aggregates expressed the presumptive MN marker DLK1 at higher levels (Supplementary Fig. 15c). Temporarily treated aggregates expressed high levels of both markers. The scRNA-seq of E9.5 mouse embryo showed that Pou3f3 and Hand2+ were expressed in a mutually exclusive manner (Supplementary Fig. 15d). IHC also showed the separation of Pou3f3+ and Hand2+ cells in the first branchial arch at E9.5, as in case of temporarily treated aggregates (Supplementary Fig. 15e).
As the branchial arch mesenchyme differentiates into craniofacial bones and cartilage in vivo1, we analyzed the osteogenic/chondrogenic potential of the aggregates by extending the culture period (Fig. 9a). On day 35, temporarily treated aggregates expressed RUNX2, a marker for osteogenic/chondrogenic lineage cells (Fig. 9b)59. Some RUNX2+ cells express SP7, an osteogenic cell marker, indicating their differentiation into this lineage59. Furthermore, in the aggregates, there were cell condensates positive for SOX9 and NKX3.2, which were expressed in the Meckel’s cartilage of mouse embryos (Fig. 9c)60,61. These results suggest spontaneous differentiation of NCC-like cells into osteogenic/chondrogenic lineages in culture.
- SEO Powered Content & PR Distribution. Get Amplified Today.
- PlatoData.Network Vertical Generative Ai. Empower Yourself. Access Here.
- PlatoAiStream. Web3 Intelligence. Knowledge Amplified. Access Here.
- PlatoESG. Carbon, CleanTech, Energy, Environment, Solar, Waste Management. Access Here.
- PlatoHealth. Biotech and Clinical Trials Intelligence. Access Here.
- Source: https://www.nature.com/articles/s41467-024-45285-0